Curing cancer
Cancer kills when it goes metastatic. Pieces of a primary tumor fly around in the body and start up lots of other tumors. If you could stop the pieces from flying around you could cure 80 percent of cancers. Cells are held together by things like the adherens junction. There is only one way to observe their dynamics, neutron spin echo spectroscopy. My laboratory is the only one in the world that can do that.
#fyp #ootd #xyzbca #explorepage #trending #collegegirls #womeninstem
Metastatic cancer remains one of the most formidable challenges in oncology because it spreads cancer cells from the primary tumor to other parts of the body, causing widespread damage. Through my experience working in a research setting, I have witnessed firsthand how critical it is to understand the mechanisms that hold cells together, such as adherens junctions. These specialized structures not only maintain tissue integrity but also play a pivotal role in preventing cancer cells from detaching and migrating. What fascinates me the most is the use of neutron spin echo spectroscopy to visualize the dynamics of these junctions at a molecular level. This technique provides unparalleled insights into how cells communicate and stay connected, which is often disrupted in metastatic cancer. Having access to such advanced technology allows researchers to study these processes in a way no other method can. Personally, I believe that targeting the mechanisms that enable tumor pieces to break off and spread could revolutionize cancer treatment. If we can develop therapies that strengthen cell adhesion or inhibit detachment, we might be able to stop metastasis before it starts. This approach could potentially cure a vast majority of cancers, as metastasis is responsible for most cancer-related deaths. Furthermore, this research highlights the importance of interdisciplinary collaboration—combining cell biology, physics, and clinical oncology to uncover novel strategies for cancer cure. I’m inspired by the potential these breakthroughs hold and hopeful that with continued support and innovation, we will see significant strides toward more effective cancer treatments that improve survival and quality of life.
